About
Chris Throgmorton has spent his career taking on complex responsibilities and helping teams deliver meaningful results. From leading over 150 Marines to directing clinical trial transparency at Neurocrine Biosciences, he has always focused on clear goals and dependable execution. As Head of Clinical Transparency at Neurocrine, he manages global clinical trial disclosure and ensures compliance with FDAAA 801, EU CTR, and other regulations. His experience across military service, biopharmaceutical companies, and government-regulated environments has shaped his direct and consistent leadership style. At Neurocrine, he created the whole clinical trial disclosure program. He developed internal procedures, vendor oversight systems, and document management platforms to streamline operations.